Back
Sarepta Therapeutics Vs. Regenxbio Industry Stock Comparison
Sell
31
SRPT
Sarepta Therapeutics
Last Price:
110.51
Seasonality Move:
16.38%
Sell
21
RGNX
Regenxbio
Last Price:
9.21
Seasonality Move:
-5.66%
Sell
31
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $110.86. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
- SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
21
Regenxbio (RGNX)
is a Sell
Is Regenxbio a Buy, Sell or Hold?
- The current Regenxbio [RGNX] share price is $9.63. The Score for RGNX is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
- RGNX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $110.86
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.05 | Sell |
Relative Strength Index (14 RSI): | 37.69 | Sell |
Chaikin Money Flow: | 693876 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (112.82 - 130.18) | Sell |
Bollinger Bands (100): | (120.21 - 144.19) | Sell |
RGNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.03 | Sell |
Relative Strength Index (14 RSI): | 46.24 | Sell |
Chaikin Money Flow: | 454637 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.02 - 10.78) | Sell |
Bollinger Bands (100): | (9.89 - 12.81) | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 110.05 | Buy |
20-day SMA: | 119.95 | Sell |
50-day SMA: | 122.58 | Sell |
200-day SMA: | 130.17 | Sell |
8-day EMA: | 110.83 | Buy |
20-day EMA: | 116.6 | Sell |
50-day EMA: | 122.63 | Sell |
200-day EMA: | 126.32 | Sell |
RGNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.36 | Sell |
20-day SMA: | 9.79 | Sell |
50-day SMA: | 10.41 | Sell |
200-day SMA: | 14.29 | Sell |
8-day EMA: | 10.03 | Sell |
20-day EMA: | 10.04 | Sell |
50-day EMA: | 10.44 | Sell |
200-day EMA: | 13.26 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.79 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.84 per share, and an increase next year of $8.55 per share.
Regenxbio Earnings Growth & RGNX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.
Sarepta Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regenxbio Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |